New Indication: Nivolumab + ipilimumab for first-line unresectable malignant pleural mesothelioma
|New Indication: Nivolumab + ipilimumab for first-line unresectable malignant pleural mesothelioma|
Lancet 2021; 397: 375–86.
Pfeiffer P, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trialhttps://doi.org/10.1016/S0140-6736(20)32714-8
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.